- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1179-190X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Adeno-Associated Virus (AAV) as a Vector for Gene Therapy ; volume:31 ; number:4 ; day:1 ; month:7 ; year:2017 ; pages:317-334 ; date:8.2017
BioDrugs ; 31, Heft 4 (1.7.2017), 317-334, 8.2017
- Schlagwort
-
Nichtmedikamentöse Therapie
- Urheber
-
Naso, Michael F.
- Beteiligte Personen und Organisationen
-
Tomkowicz, Brian
Perry, William L.
Strohl, William R.
SpringerLink (Online service)
- DOI
-
10.1007/s40259-017-0234-5
- URN
-
urn:nbn:de:1111-201710254211
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:21 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Naso, Michael F.
- Tomkowicz, Brian
- Perry, William L.
- Strohl, William R.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Molecular design for recombinant adeno-associated virus (rAAV) vector production
Adeno-Associated Virus (AAV) vectors in gene therapy
Adeno‐associated virus (AAV)-based gene therapy for glioblastoma
Adeno-associated virus: from defective virus to effective vector
Molecular design of controllable recombinant adeno‐associated virus (AAV) expression systems for enhanced vector production
Immunogenicity of Recombinant Adeno-Associated Virus (AAV) Vectors for Gene Transfer
Adeno-associated virus display : in vitro evolution of AAV retargeted vectors
Small but increasingly mighty: new insights into Adeno-associated virus (AAV) capsid biology and implications for AAV vector optimization
Small but increasingly mighty: New insights into Adeno-associated virus (AAV) capsid biology and implications for AAV vector optimization
Hepatocellular Carcinoma Is a Natural Target for Adeno-Associated Virus (AAV) 2 Vectors
Induction of hepatitis E virus anti-ORF3 antibodies from systemic administration of a muscle-specific adeno-associated virus (AAV) vector
Influence of the SUMOylation pathway on adeno-associated virus vector transduction
Molecular design for recombinant adeno-associated virus (rAAV) vector production
Adeno-Associated Virus (AAV) vectors in gene therapy
Adeno‐associated virus (AAV)-based gene therapy for glioblastoma
Adeno-associated virus: from defective virus to effective vector
Molecular design of controllable recombinant adeno‐associated virus (AAV) expression systems for enhanced vector production
Immunogenicity of Recombinant Adeno-Associated Virus (AAV) Vectors for Gene Transfer
Adeno-associated virus display : in vitro evolution of AAV retargeted vectors
Small but increasingly mighty: new insights into Adeno-associated virus (AAV) capsid biology and implications for AAV vector optimization
Small but increasingly mighty: New insights into Adeno-associated virus (AAV) capsid biology and implications for AAV vector optimization
Hepatocellular Carcinoma Is a Natural Target for Adeno-Associated Virus (AAV) 2 Vectors
Induction of hepatitis E virus anti-ORF3 antibodies from systemic administration of a muscle-specific adeno-associated virus (AAV) vector
Influence of the SUMOylation pathway on adeno-associated virus vector transduction
Molecular design for recombinant adeno-associated virus (rAAV) vector production
Adeno-Associated Virus (AAV) vectors in gene therapy
Adeno‐associated virus (AAV)-based gene therapy for glioblastoma
Adeno-associated virus: from defective virus to effective vector
Molecular design of controllable recombinant adeno‐associated virus (AAV) expression systems for enhanced vector production
Immunogenicity of Recombinant Adeno-Associated Virus (AAV) Vectors for Gene Transfer
Adeno-associated virus display : in vitro evolution of AAV retargeted vectors
Small but increasingly mighty: new insights into Adeno-associated virus (AAV) capsid biology and implications for AAV vector optimization
Small but increasingly mighty: New insights into Adeno-associated virus (AAV) capsid biology and implications for AAV vector optimization
Hepatocellular Carcinoma Is a Natural Target for Adeno-Associated Virus (AAV) 2 Vectors
Induction of hepatitis E virus anti-ORF3 antibodies from systemic administration of a muscle-specific adeno-associated virus (AAV) vector